Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 studyArvind Dasari, Cathy Eng, James C. Yao et al.|The Lancet|2023Cited by 319
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trialCharles S. Fuchs, Francesco Di Costanzo, Kohei Shitara et al.|The Lancet Oncology|2019Cited by 282
Az onkokardiológiai ellátás új irányelveiAndrás Nagy, Judit Kocsis, Mária Lódi et al.|University of Debrecen Electronic Archive (University of Debrecen)|2017Cited by 0